Literature DB >> 11185711

CT arterial portography in the staging of pancreatic malignancy.

S Varshney1, C N Hacking, C D Johnson.   

Abstract

BACKGROUND: Detection of metastatic liver disease and malignant involvement of major peripancreatic vessels is important to determine resectability of pacreatic malignancy. Computed tomography with arterial portography (CTAP) is the most sensitive method for detection of colorectal liver metastases; it can also detect malignant vascular involvement. We have assessed CTAP in patients with pancreatic cancer considered suitable for resection after standard ultrasonography (US) and computed tomography (CT) examination.
METHOD: CTAP was performed in 18 patients (8 with a biliary stent). All patients had previous US and CT with no clear evidence of irresectability. Findings of CTAP were compared with the prior CT and with findings at operation or clinical progress.
RESULTS: CTAP suggested liver metastases in 7 patients. Three were confirmed at operation or at follow-up (sensitivity for detection of metastases in CT negative patients of 75%). There were 4 false-positive assessments (specificity, 71%). One further patient developed liver metastases within 6 mo after resection (1 false-negative). Nine patients had vascular involvement at operation. There was 1 false-positive and one false-negative assessment (sensitivity, 89% and specificity, 89%). CTAP detected vascular involvement in 4 patients in whom it was not detected by CT.
CONCLUSION: This preliminary study suggests that CTAP is a sensitive test for detection of liver metastases and vascular involvement in patients with pancreatic malignancy. This invasive test should be reserved for patients who are considered operable on the basis of other preoperative tests.

Entities:  

Mesh:

Year:  2000        PMID: 11185711     DOI: 10.1385/IJGC:28:1:59

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  32 in total

1.  Use of spiral and non-spiral computed tomography arterial portography in the detection of potentially malignant liver masses.

Authors:  N Young; T Sing; K P Wong; M Hollands; N Tait
Journal:  J Gastroenterol Hepatol       Date:  1997-05       Impact factor: 4.029

2.  Magnetic resonance imaging of the pancreas with gadolinium-DTPA.

Authors:  J L Chezmar; R C Nelson; W C Small; M E Bernardino
Journal:  Gastrointest Radiol       Date:  1991

3.  Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography.

Authors:  P Soyer; M Levesque; D Elias; G Zeitoun; A Roche
Journal:  Radiology       Date:  1992-05       Impact factor: 11.105

4.  Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging.

Authors:  J P Heiken; P J Weyman; J K Lee; D M Balfe; D Picus; E M Brunt; M W Flye
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

5.  Who are we missing and why?

Authors:  S J Cutler; M H Myers; P L White
Journal:  Cancer       Date:  1976-01       Impact factor: 6.860

6.  Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation.

Authors:  R C Nelson; J L Chezmar; P H Sugarbaker; M E Bernardino
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

7.  Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography.

Authors:  P Soyer; D A Bluemke; R H Hruban; J V Sitzmann; E K Fishman
Journal:  Radiology       Date:  1994-10       Impact factor: 11.105

Review 8.  Pancreatic and ampullary carcinoma. Ultrasound, computed tomography, magnetic resonance imaging and angiography.

Authors:  H J Brambs; C D Claussen
Journal:  Endoscopy       Date:  1993-01       Impact factor: 10.093

9.  Carcinoma of the pancreas in nonjaundiced patients. A silent disease.

Authors:  N Sheth; G Dalbagni; R E Rothenberg; R D LaRaja
Journal:  Am Surg       Date:  1985-05       Impact factor: 0.688

10.  Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms.

Authors:  G M Fuhrman; C Charnsangavej; J L Abbruzzese; K R Cleary; R G Martin; C J Fenoglio; D B Evans
Journal:  Am J Surg       Date:  1994-01       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.